Explicit|10|66|217..228|1,0|In addition|||in addition|||Expansion.Conjunction||||Wr|Comm|Null|Null||||9..213|0|Delmed Inc. 's top two officers resigned and were succeeded by executives of Fresenius USA Inc. and its parent, Fresenius AG, a major Delmed holder that has been negotiating to acquire a controlling stake|Inh|Null|Null|Null||||319..421|1,3,1|negotiations about pricing had collapsed between it and a major distributor, National Medical Care Inc|Ot|Comm|Null|Null|314..318|1,2,1;1,2,3;1,3,0|said||||||
Implicit|10|66||||508|3||although||Comparison.Concession.Contra-expectation||||Ot|Comm|Null|Null|425..436|2,0;2,1,0;2,2|Delmed said|437..506|2,1,1|Robert S. Ehrlich resigned as chairman, president and chief executive|Inh|Null|Null|Null||||508..564|3|Mr. Ehrlich will continue as a director and a consultant|Inh|Null|Null|Null|||||||||
Explicit|10|66|638..642|4,0,1|also|||also|||Expansion.Conjunction||||Wr|Comm|Null|Null||||437..506|2,1,1|Robert S. Ehrlich resigned as chairman, president and chief executive|Ot|Comm|Null|Null|425..436|2,0;2,1,0;2,2|Delmed said|566..636;643..651|4,0,0;4,0,2|Leslie I. Shapiro, chief operating officer and chief financial officer resigned|Ot|Comm|Null|Null|653..669|4,1;4,2;4,3;4,4|the company said||||||
Implicit|10|66||||789|6||and||Expansion.Conjunction||||Wr|Comm|Null|Null||||673..787|5|Mr. Ehrlich was succeeded as chairman by Gerd Krick, a director of Fresenius, a West German pharmaceutical concern|Inh|Null|Null|Null||||789..892|6|Ben Lipps, president of Fresenius USA, was named president, chief executive and chief operating officer|Inh|Null|Null|Null|||||||||
Implicit|10|66||||1101|10||in addition||Expansion.Conjunction||||Wr|Comm|Null|Null||||1036..1099|9|Fresenius owns about 42% of Delmed's fully diluted common stock|Inh|Null|Null|Null||||1101..1303|10|The two companies have been discussing a transaction under which Fresenius would buy Delmed stock for cash to bring its beneficial ownership to between 70% and 80% of Delmed's fully diluted common stock|Inh|Null|Null|Null|||||||||
Explicit|10|66|1321..1325|11,1|also|||also|||Expansion.Conjunction||||Wr|Comm|Null|Null||||1154..1303|10,1,1,1,1,1|under which Fresenius would buy Delmed stock for cash to bring its beneficial ownership to between 70% and 80% of Delmed's fully diluted common stock|Inh|Null|Null|Null||||1305..1320;1326..1364|11,0;11,2;11,3|The transaction would combine Fresenius USA and Delmed|Inh|Null|Null|Null|||||||||
Implicit|10|66||||1690|14||however||Comparison.Concession.Contra-expectation||||Ot|Comm|Null|Null|1681..1689|14,0;14,1,0;14,2;14,3|It added|1602..1678|13,3,1|it "continues to explore the possibility of a combination with Fresenius USA|Ot|Comm|Null|Null|1579..1601|13,0;13,1;13,2;13,3,0;13,4;13,5|Yesterday, Delmed said|1690..1812|14,1,1|that it is apparent that any terms of a combination "would be substantially less favorable than those previously announced|Inh|Null|Null|Null|||||||||
Explicit|10|66|1817..1822|15,0,0,0|While|||while|||Comparison.Concession.Expectation||||Wr|Comm|Null|Null||||1904..2028|15,0,1;15,0,2;15,0,3|Delmed will continue to supply dialysis products through National Medical after their exclusive agreement ends in March 1990|Ot|Comm|Null|Null|2030..2041|15,1;15,2;15,3;15,4|Delmed said|1823..1902|15,0,0,1|the discussions between Delmed and National Medical Care have been discontinued|Inh|Null|Null|Null|||||||||
Explicit|10|66|1978..1983|15,0,3,1,2,0|after|||after|||Temporal.Asynchronous.Succession||||Ot|Comm|Null|Null|2030..2041|15,1;15,2;15,3;15,4|Delmed said|1904..1977|15,0,1;15,0,2;15,0,3,0;15,0,3,1,0;15,0,3,1,1|Delmed will continue to supply dialysis products through National Medical|Inh|Null|Null|Null||||1984..2028|15,0,3,1,2,1|their exclusive agreement ends in March 1990|Inh|Null|Null|Null|||||||||
Explicit|10|66|2043..2054|16,0,0|In addition|||in addition|||Expansion.Conjunction||||Wr|Comm|Null|Null||||1817..2028|15,0|While the discussions between Delmed and National Medical Care have been discontinued, Delmed will continue to supply dialysis products through National Medical after their exclusive agreement ends in March 1990|Ot|Comm|Null|Null|2030..2041|15,1;15,2;15,3;15,4|Delmed said|2056..2120|16,0,1;16,0,2;16,0,3|Delmed is exploring distribution arrangements with Fresenius USA|Ot|Comm|Null|Null|2122..2133|16,1;16,2;16,3;16,4|Delmed said||||||
